Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Joint Bone Spine
|
October 11, 2005
Is restless legs syndrome underrecognized? Current management
Pascale Vergne-Salle, Damien Coyral, Karine Dufauret, et al.
Joint Bone Spine
|
January 26, 2010
Ultrasonography in chondrocalcinosis
Carine Dufauret-Lombard, Pascale Vergne-Salle, Anne Simon, et al.
Musculoskeletal Care
|
July 5, 2023
Cross-perspectives on care pathways for painful osteoarthritis: A qualitative analysis in patients and healthcare professionals
Serge Perrot, Guillaume Roucoux, Philippe Bertin, et al.
Environmental Microbiology Reports
|
May 11, 2021
Metatranscriptomic outlook on green and brown food webs in acid mine drainage
Frédéric Plewniak, Simona Crognale, Odile Bruneel, et al.
Cytokine
|
August 16, 2005
Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes
Pascale Vergne-Salle, David Yannick Léger, Philippe Bertin, et al.
Microbiology (Reading, England)
|
January 2, 2004
GadE (YhiE): a novel activator involved in the response to acid environment in Escherichia coli
Florence Hommais, Evelyne Krin, Jean-Yves Coppée, et al.
Bulletin De L'Academie Nationale De Medecine
|
January 2, 2007
[Contribution of sacroiliac magnetic resonance imaging (MRI) to the evaluation of infliximab efficacy in spondyloarthropathy (a prospective study of 34 patients)]
Richard Treves, Carine Dufauret-Lombard, Pascale Vergne-Salle, et al.
Joint Bone Spine
|
September 26, 2006
Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study
Thierry Conrozier, Philippe Bertin, François Bailleul, et al.
European Journal of Pain (London, England)
|
November 2, 2010
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia
Pascale Vergne-Salle, Carine Dufauret-Lombard, Christine Bonnet, et al.
Joint Bone Spine
|
November 8, 2008
Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion
Pascale Vergne-Salle, Othmane Mejjad, Rose Marie Javier, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Joint Bone Spine
|
October 11, 2005
Is restless legs syndrome underrecognized? Current management
Pascale Vergne-Salle, Damien Coyral, Karine Dufauret, et al.
Joint Bone Spine
|
January 26, 2010
Ultrasonography in chondrocalcinosis
Carine Dufauret-Lombard, Pascale Vergne-Salle, Anne Simon, et al.
Musculoskeletal Care
|
July 5, 2023
Cross-perspectives on care pathways for painful osteoarthritis: A qualitative analysis in patients and healthcare professionals
Serge Perrot, Guillaume Roucoux, Philippe Bertin, et al.
Environmental Microbiology Reports
|
May 11, 2021
Metatranscriptomic outlook on green and brown food webs in acid mine drainage
Frédéric Plewniak, Simona Crognale, Odile Bruneel, et al.
Cytokine
|
August 16, 2005
Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes
Pascale Vergne-Salle, David Yannick Léger, Philippe Bertin, et al.
Microbiology (Reading, England)
|
January 2, 2004
GadE (YhiE): a novel activator involved in the response to acid environment in Escherichia coli
Florence Hommais, Evelyne Krin, Jean-Yves Coppée, et al.
Bulletin De L'Academie Nationale De Medecine
|
January 2, 2007
[Contribution of sacroiliac magnetic resonance imaging (MRI) to the evaluation of infliximab efficacy in spondyloarthropathy (a prospective study of 34 patients)]
Richard Treves, Carine Dufauret-Lombard, Pascale Vergne-Salle, et al.
Joint Bone Spine
|
September 26, 2006
Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study
Thierry Conrozier, Philippe Bertin, François Bailleul, et al.
European Journal of Pain (London, England)
|
November 2, 2010
A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia
Pascale Vergne-Salle, Carine Dufauret-Lombard, Christine Bonnet, et al.
Joint Bone Spine
|
November 8, 2008
Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion
Pascale Vergne-Salle, Othmane Mejjad, Rose Marie Javier, et al.
Page
of 7